‘Our Case Is About Standing Up To Patent Abuse’ – Sandoz Appeals Amgen Etanercept Antitrust Ruling

Insists Enbrel’s ‘Unprecedented’ Patent Extension Was Unlawful

 
• By Dave Wallace
  
Sandoz has now appealed against the dismissal of its antitrust lawsuit (Shutterstock)

More from Legal & IP

More from Generics Bulletin